Novavax has inked another settlement for a past COVID-19 vaccine supply deal. | Novavax has inked another settlement for a ...

An Omicron-specific, self-amplifying mRNA booster vaccine for ... The event brings together over 900 attendees from both academic institutions and leading pharma and biotech companies. The 2024 ...

Please see the forward-looking statement disclaimer on the company's press release issued earlier today, as well as the risk factors section in our most recent form 10-K and in subsequent ... Meiji ...

The booster shot – called mRNA-1273.211 – offered better and longer-lasting protection compared to the original SpikeVax shot against all SARS-CoV-2 variants, including the prevailing Omicron ...

Request To Download Free Sample of This Strategic Report @- The Global X-ray Photoelectron Spectroscopy (XPS) Market is poised for significant growth, with projections indicating a reach of over USD ...

The facility is the centrepiece of a 10-year agreement-in-principle between ... vaccine candidate against the newer variants like Omicron if authorised, for delivery in 2022 and 2023.

Zealand Pharma A/S briefly reclaimed its position as this year’s ... the Danish biotech firm’s experimental weight-loss drug ...

AbbVie’s deal flop and NFL high-profile draft busts have a lot in common.

Pfizer is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist ...

While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.

Novo Nordisk chief financial officer Karsten Munk Knudsen said on Wednesday the company was aware of reports of 10 deaths and ...

On the heels of releasing its latest financial statement, Vancouver-based biotechnology company Absci announced it has met its first milestone in its collaboration with pharmaceutical giant AstraZenec ...